Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DNC012054

Drug Information
NameIndol-1-yl-propyl-pyridin-4-yl-amine
Indol-1-yl-propyl-pyridin-4-yl-amine(Besipirdine)
IndicationNot AvailableExperimental    
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C16H17N3/c1-2-12-18(15-7-10-17-11-8-15)19-13-9-14-5-3-4-6-16(1
4)19/h3-11,13H,2,12H2,1H3
InChIKeyOTPPJICEBWOCKD-UHFFFAOYSA-N
Canonical SMILESCCCN(C1=CC=NC=C1)N2C=CC3=CC=CC=C32    
TargetAlpha-2a adrenergic receptorInhibitor[1]
Alpha-2b adrenergic receptorInhibitor[1]
Alpha-2c adrenergic receptorInhibitor[1]
Sodium channel protein type V alpha subunitInhibitor[2]
Sodium channel protein type VI alpha subunit Inhibitor[2]
Ref 1J Med Chem. 1996 Jan 19;39(2):570-81.Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease. To Reference
Ref 2J Med Chem. 2001 Jan 18;44(2):115-37.Medicinal chemistry of neuronal voltage-gated sodium channel blockers. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543